Clearmind Medicine (FRA:CWY0) Forward Dividend Yield % : 0.00% (As of Jun. 19, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Forward Dividend Yield %?

As of today (2024-06-19), the Forward Annual Dividend Yield of Clearmind Medicine is 0.00%.

As of today (2024-06-19), the Trailing Annual Dividend Yield of Clearmind Medicine is 0.00%.

FRA:CWY0's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.69
* Ranked among companies with meaningful Forward Dividend Yield % only.

Clearmind Medicine's Dividends per Share for the three months ended in Apr. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Clearmind Medicine's Forward Dividend Yield %

For the Biotechnology subindustry, Clearmind Medicine's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearmind Medicine's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Forward Dividend Yield % falls into.

Clearmind Medicine Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Clearmind Medicine (FRA:CWY0) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Clearmind Medicine Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (FRA:CWY0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

CMND:USA CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (FRA:CWY0) Headlines

No Headlines